Page last updated: 2024-12-08

md 780236

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MD 780236: RN given refers to parent cpd without isomeric designation; structure given in first source for (+-)-isomer; MD 780236; (R)-somer: MD 240928; (S)-isomer: MD 240931 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID158621
CHEMBL ID326373
SCHEMBL ID10852805
MeSH IDM0114333

Synonyms (14)

Synonym
3-[4-(3-chloro-benzyloxy)-phenyl]-5-methylaminomethyl-oxazolidin-2-one;hydrochloride
bdbm50042592
md 780236
CHEMBL326373 ,
3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-(methylaminomethyl)-1,3-oxazolidin-2-one
2-oxazolidinone, 3-(4-((3-chlorophenyl)methoxy)phenyl)-5-((methylamino)methyl)-
3-(4-((3-chlorophenyl)methoxy)phenyl)-5-((methylamino)methyl)oxazolidin-2-one
einecs 277-469-5
73423-36-6
2-oxazolidinone,3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]-
SCHEMBL10852805
3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]oxazolidin-2-one
DTXSID10868794
3-{4-[(3-chlorophenyl)methoxy]phenyl}-5-[(methylamino)methyl]-1,3-oxazolidin-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] BBos taurus (cattle)Ki200.00000.05401.83906.0000AID102570
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
primary amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
monoamine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] BBos taurus (cattle)
mitochondrial outer membraneAmine oxidase [flavin-containing] BBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID102574Kinetic constant for inactivation of MAO B from replot of half-lives of inactivation1993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation.
AID102570Kinetic constant for inactivation of MAO B from replot of half-lives of inactivation1993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (91.67)18.7374
1990's1 (8.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.71 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]